Biomarkers of drug-induced liver injury.

Acetaminophen Diagnosis Drug regulation Hepatotoxicity Idiosyncratic drug-induced liver injury Predictive value Prognosis

Journal

Advances in pharmacology (San Diego, Calif.)
ISSN: 1557-8925
Titre abrégé: Adv Pharmacol
Pays: United States
ID NLM: 9015397

Informations de publication

Date de publication:
2019
Historique:
entrez: 17 7 2019
pubmed: 17 7 2019
medline: 13 2 2020
Statut: ppublish

Résumé

Drug-induced liver injury (DILI) is a major clinical and regulatory challenge. As a result, interest in DILI biomarkers is growing. So far, considerable progress has been made in identification of biomarkers for diagnosis (acetaminophen-cysteine protein adducts), prediction (genetic biomarkers), and prognosis (microRNA-122, high mobility group box 1 protein, keratin-18, glutamate dehydrogenase, mitochondrial DNA). Many of those biomarkers also provide mechanistic insight. The purpose of this chapter is to review major advances in DILI biomarker research over the last decade, and to highlight some of the challenges involved in implementation. Although much work has been done, more liver-specific biomarkers, more DILI-specific biomarkers, and better prognostic biomarkers for survival are all still needed. Furthermore, more work is needed to define reference intervals and medical decision limits.

Identifiants

pubmed: 31307588
pii: S1054-3589(19)30009-2
doi: 10.1016/bs.apha.2019.02.001
pmc: PMC7351790
mid: NIHMS1599892
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

221-239

Subventions

Organisme : NIGMS NIH HHS
ID : P20 GM103549
Pays : United States
Organisme : NIGMS NIH HHS
ID : P30 GM118247
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK102142
Pays : United States

Informations de copyright

© 2019 Elsevier Inc. All rights reserved.

Références

Hepatology. 2013 Aug;58(2):777-87
pubmed: 23390034
J Dig Dis. 2019 Jan;20(1):2-10
pubmed: 30378260
Toxicol Sci. 2015 Feb;143(2):268-76
pubmed: 25359176
Biomark Med. 2014;8(2):147-59
pubmed: 24521011
Expert Opin Drug Saf. 2018 Feb;17(2):117-123
pubmed: 29215916
J Clin Pharmacol. 2005 Oct;45(10):1165-71
pubmed: 16172181
BMC Gastroenterol. 2011 Mar 14;11:20
pubmed: 21401949
Gastroenterology. 2007 Jan;132(1):272-81
pubmed: 17241877
Liver. 1992 Jun;12(3):132-6
pubmed: 1380112
Toxicol Lett. 2000 Aug 16;116(3):171-81
pubmed: 10996478
Pediatr Transplant. 2009 Mar;13(2):223-30
pubmed: 18643912
J Clin Pharmacol. 2001 Aug;41(8):846-51
pubmed: 11504272
Expert Opin Drug Metab Toxicol. 2014 Jul;10(7):1005-17
pubmed: 24836926
J Pediatr Gastroenterol Nutr. 2015 Jul;61(1):102-7
pubmed: 25859823
J Hepatol. 2012 May;56(5):1070-9
pubmed: 22266604
JAMA. 2006 Jul 5;296(1):87-93
pubmed: 16820551
Pharmacogenomics J. 2012 Dec;12(6):499-506
pubmed: 21862974
Arch Toxicol. 2014 Feb;88(2):391-401
pubmed: 23979652
Hepatology. 2011 Mar;53(3):974-82
pubmed: 21319200
J Hepatol. 2007 Jul;47(1):128-34
pubmed: 17400324
Clin Med (Lond). 2015 Jun;15(3):244-7
pubmed: 26031973
Br J Clin Pharmacol. 2017 Sep;83(9):2027-2033
pubmed: 28257154
Drug Metab Dispos. 2009 Aug;37(8):1779-84
pubmed: 19439490
J Pharmacol Exp Ther. 1989 Jan;248(1):190-6
pubmed: 2913271
Liver Int. 2014 Mar;34(3):367-78
pubmed: 24118944
Clin Ther. 2001 Oct;23(10):1603-14
pubmed: 11726000
J Pharmacol Exp Ther. 1987 May;241(2):527-33
pubmed: 3572810
Clin Ther. 2016 May;38(5):1029-41
pubmed: 27021604
BMC Med. 2016 Feb 04;14:10
pubmed: 26843061
Ann Emerg Med. 1991 Oct;20(10):1058-63
pubmed: 1928874
Drug Metab Dispos. 2002 Apr;30(4):446-51
pubmed: 11901099
Liver Int. 2017 Mar;37(3):377-384
pubmed: 27429052
J Clin Invest. 2012 Apr;122(4):1574-83
pubmed: 22378043
Hepatology. 2014 Oct;60(4):1336-45
pubmed: 24923598
Clin Pharmacol Ther. 2012 Sep;92(3):376-80
pubmed: 22850601
Hepatology. 2012 Nov;56(5):1971-82
pubmed: 22532075
Clin Pharmacol Ther. 2001 Sep;70(3):280-6
pubmed: 11557916
Hepatology. 2010 Jul;52(1):303-12
pubmed: 20578157
Liver Transpl. 2015 Jun;21(6):847-54
pubmed: 25825217
EXCLI J. 2016 Dec 15;15:817-828
pubmed: 28337112
Expert Rev Mol Diagn. 2018 Sep;18(9):797-807
pubmed: 30080986
Clin Pharmacol Ther. 2017 Apr;101(4):469-480
pubmed: 27861792
Gene Expr. 2017 Nov 27;17(4):301-312
pubmed: 28770701
Chem Res Toxicol. 2009 Apr;22(4):699-707
pubmed: 19256530
Toxicol Appl Pharmacol. 2010 Sep 15;247(3):169-78
pubmed: 20637792
Gastroenterology. 1989 Aug;97(2):439-45
pubmed: 2490426
J Pathol. 1999 Apr;187(5):567-72
pubmed: 10398123
Clin Pharmacol Ther. 2013 Dec;94(6):678-86
pubmed: 23863877
World J Gastroenterol. 2007 Feb 14;13(6):837-44
pubmed: 17352011
Transplant Proc. 2004 Oct;36(8):2359-61
pubmed: 15561249
Toxicol Appl Pharmacol. 2014 Sep 15;279(3):266-274
pubmed: 24905542
Liver Int. 2014 Mar;34(3):325-7
pubmed: 25839081
Antioxid Redox Signal. 2016 Apr 20;24(12):620-34
pubmed: 26715031
Hepatology. 2011 Nov;54(5):1767-76
pubmed: 22045675
J Med Toxicol. 2016 Mar;12(1):100-6
pubmed: 26341088
Am J Physiol Gastrointest Liver Physiol. 2014 Aug 1;307(3):G355-64
pubmed: 24924744
Toxicol Sci. 2013 Apr;132(2):276-83
pubmed: 23339181
Clin Gastroenterol Hepatol. 2017 Apr;15(4):555-562.e3
pubmed: 27641661
Toxicol Appl Pharmacol. 2015 Apr 15;284(2):180-7
pubmed: 25708609
Food Chem Toxicol. 2018 May;115:273-283
pubmed: 29534981
Toxicol Lett. 2019 Feb;301:125-132
pubmed: 30447259
Lancet. 2002 Mar 2;359(9308):727-32
pubmed: 11888582
Liver Int. 2017 May;37(5):757-764
pubmed: 27860186
Hepatology. 2005 Jan;41(1):26-31
pubmed: 15690478
Liver Int. 2018 Jul;38(7):1322-1329
pubmed: 29222960
Liver Transpl. 2016 Apr;22(4):505-15
pubmed: 26421889
Lancet Gastroenterol Hepatol. 2018 Feb;3(2):104-113
pubmed: 29146439
Toxicol Sci. 2006 Nov;94(1):217-25
pubmed: 16896059
Semin Cell Dev Biol. 2018 Oct;82:79-85
pubmed: 29329946
J Crit Care. 2016 Aug;34:103-6
pubmed: 27288619
Toxicol Appl Pharmacol. 2013 Jun 15;269(3):240-9
pubmed: 23571099
Scand J Gastroenterol. 2016;51(5):594-600
pubmed: 26653080
Hepatology. 2019 Feb;69(2):760-773
pubmed: 29357190
Semin Liver Dis. 2008 May;28(2):142-52
pubmed: 18452114
Curr Drug Saf. 2007 Sep;2(3):177-85
pubmed: 18690965
Alcohol. 2006 Jan;38(1):45-9
pubmed: 16762691
Arch Intern Med. 1981 Feb 23;141(3 Spec No):380-5
pubmed: 7469629
Hepatology. 2011 Feb;53(2):567-76
pubmed: 21274877
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12169-74
pubmed: 25092309
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Mar 15;985:131-41
pubmed: 25681644
Hepatology. 2012 May;55(5):1640-2; author reply 1642-3
pubmed: 22213067
Pediatrics. 1978 Nov;62(5 Pt 2 Suppl):898-903
pubmed: 724342
PLoS One. 2018 Oct 25;13(10):e0206389
pubmed: 30359443
Best Pract Res Clin Gastroenterol. 2012 Feb;26(1):3-16
pubmed: 22482521
Semin Immunol. 2018 Aug;38:40-48
pubmed: 29530410
Semin Liver Dis. 2014 May;34(2):123-33
pubmed: 24879978
J Hepatol. 2017 Apr;66(4):836-848
pubmed: 27913221
Toxicol Sci. 2002 Jun;67(2):322-8
pubmed: 12011492
Regul Toxicol Pharmacol. 2000 Aug;32(1):56-67
pubmed: 11029269
Clin Toxicol (Phila). 2016;54(1):53-5
pubmed: 26574140
Nature. 2002 Jul 11;418(6894):191-5
pubmed: 12110890
Expert Rev Gastroenterol Hepatol. 2014 Sep;8(7):721-3
pubmed: 24857265
J Pediatr Gastroenterol Nutr. 2005 May;40(5):575-81
pubmed: 15861019
Hepatology. 2003 Apr;37(4):924-30
pubmed: 12668988
Liver Int. 2011 Sep;31(8):1127-36
pubmed: 21745283
Clin Gastroenterol Hepatol. 2019 May;17(6):1201-1203
pubmed: 30103039
EMBO J. 2003 Oct 15;22(20):5551-60
pubmed: 14532127
Clin Infect Dis. 2006 Sep 15;43(6):783-6
pubmed: 16912957

Auteurs

Mitchell R McGill (MR)

Department of Environmental and Occupational Health, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, United States; Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR, United States. Electronic address: mmcgill@uams.edu.

Hartmut Jaeschke (H)

Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH